EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

JMA Poster session 02 - ENT/Ocular allergy/Asthma/Environmental allergy/One health

Friday 31 May, 16:45 PM - 18:15 PM Valencia, Spain
Poster Zone JMA Sessions
16:45
Adiposity and predicted fractional exhaled nitric oxide in non-asthmatic children
16:45
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
16:45
Allergen identification in an emerging predatory mite, Cheyletus eruditus. Cross-reactive analysis with other mite allergens
16:45
Differential gene expression analysis in ten year old asthmatic children from the PASTURE cohort
16:45
Evaluation of The Development of Respiratory Tract Allergic Disease in Patients With Cow's Milk Allergy
16:45
IL-17RB-expressing human B cells are responsive to IL-25 with enhanced antibody production
16:45
Immuno-metabolic reprogramming of bronchial epithelium in asthma
16:45
Long-term allergic diseases outcomes in long COVID: multinational population-based cohort studies from South Korea, Japan and the UK
16:45
Modulation of IgE-dependent ECP production by human neutrophils
16:45
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
16:45
Multi-omic analyses reveal new potential biomarkers for monitoring asthmatic patients treated with either Mepolizumab or Omalizumab
16:45
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
16:45
Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma
16:45
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
16:45
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
16:45
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity

Chairs

Speakers